The American Journal of Medicine
Volume 122, Issue 7 , Pages 595-596 , July 2009

It's Time to Bail Out Seniors Trapped in the Medicare Donut Hole!

References 

  1. Kaiser Family Foundation, the Medicare prescription drug benefit fact sheet, March, 2009. http://www,kff,org/medicare/upload/7044_09.pdfLast accessed March 15, 2009.
  2. Steinberg EP, Guiterrez B, Momani A, et al. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Affairs. 2000;19:198–211
  3. Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: A ten-year trend. Health Affairs. 2009;28:15–25
  4. Masoudi FA, Baillie CA, Wang Y, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165:2069–2076
  5. Dalen JE, Hartz DJ. Medicare prescription drug coverage: A very long wait for a very modest benefit. Am J Med. 2005;118:325–329
  6. Iglehart JK. Medicare and drug pricing. N Engl J Med. 2003;348:1590–1597
  7. House committee on oversight and government reform, July, 2008. http://www.medicarerights.org/pdf/072408_PrechtTestimonyonPartD.pdfLast accessed April 23, 2009.
  8. Altman DE. The new Medicare prescription-drug legislation. N Engl J Med. 2004;350:9–10
  9. Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Affairs. 2009;28:w305–w316
  10. Zhang Y, Donohue JM, Newhouse JP, et al. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Affairs. 2009;28:w317–w325
  11. Kaiser Family Foundation, The Medicare Part D coverage gap: Costs and consequences in 2007. August 2008. http://www.kff.org/medicare/upload/7811.pdfLast accessed March 15, 2009.
  12. Center for Studying Health System Change, More nonelderly Americans dace problems affording prescription drugs (January, 2009). http://www.hschange.com/CONTENT/1039/Last accessed March 17, 2009.
  13. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs?. Health Affairs. 2004;23:213–222
  14. Christian-Herman J, Emons M, George D. Effects of generic-only drug coverage in a Medicare HMO. Health Affairs. 2004;23:w455–w468
  15. Hsu J, Price M, Huang J. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354:2349–2359
  16. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421–429
  17. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560–2571
  18. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  19. Moeller JF, Miller GE, Banthin JS. Looking inside the nation's medicine cabinet: Trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001. Health Affairs. 2004;23:217–225
  20. Anderson GF, Shea DG, Hussey PS, et al. Doughnut holes and price controls. Health Affairs. 2004;23:396–404

PII: S0002-9343(09)00292-7

doi: 10.1016/j.amjmed.2009.03.016

The American Journal of Medicine
Volume 122, Issue 7 , Pages 595-596 , July 2009

Article Tools